Panagora Asset Management Inc Ocular Therapeutix, Inc Transaction History

Panagora Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.61 - $4.41 $4,711 - $7,960	1,805 Added 4.88%	38,757 $108,000
Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $192,749 - $306,325	-47,127 Reduced 56.05%	36,952 $153,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $4,048 - $7,020	-1,345 Reduced 1.57%	84,079 $338,000
Q1 2022 May 12, 2022	BUY	$4.83 - $7.35 $267,321 - $406,793	55,346 Added 184.01%	85,424 $423,000
Q4 2021 Feb 10, 2022	BUY	$6.16 - $12.07 $185,280 - $363,041	30,078 New	30,078 $210,000

Q3 2021 Nov 10, 2021	SELL	$9.7 - $14.34 $13,366 - $19,760	-1,378 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$13.43 - $19.16 $13,644 - $19,466	1,016 Added 280.66%	1,378 $20,000
Q4 2020 Feb 10, 2021	SELL	$7.91 - $22.95 $5,703 - $16,546	-721 Reduced 66.57%	362 $7,000
Q3 2020 Nov 13, 2020	SELL	$7.36 - $9.87 $8,228 - $11,034	-1,118 Reduced 50.8%	1,083 $8,000
Q1 2020 May 14, 2020	SELL	$3.95 - $7.4 $66,257 - $124,127	-16,774 Reduced 88.4%	2,201 $11,000
Q4 2019 Feb 12, 2020	BUY	$2.57 - $4.73 $48,765 - $89,751	18,975 New	18,975 $75,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.